Tamar Tadmor
Tamar Tadmor
Head of Haematology Unit and Blood Bank in Bnai Zion Medical Center
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia
MR Grever, O Abdel-Wahab, LA Andritsos, V Banerji, J Barrientos, ...
Blood, The Journal of the American Society of Hematology 129 (5), 553-560, 2017
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
RJ Kreitman, C Dearden, PL Zinzani, J Delgado, L Karlin, T Robak, ...
Leukemia 32 (8), 1768-1777, 2018
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial
MA Dimopoulos, F Gay, F Schjesvold, M Beksac, R Hajek, KC Weisel, ...
The Lancet 393 (10168), 253-264, 2019
The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model
T Tadmor, Y Zhang, HM Cho, ER Podack, JD Rosenblatt
Cancer Immunology, Immunotherapy 60, 609-619, 2011
Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing
YC Cohen, M Zada, SY Wang, C Bornstein, E David, A Moshe, B Li, ...
Nature medicine 27 (3), 491-503, 2021
Primary diffuse large B-cell lymphoma of the breast: looking at pathogenesis, clinical issues and therapeutic options
A Aviv, T Tadmor, A Polliack
Annals of oncology 24 (9), 2236-2244, 2013
Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination
Y Herishanu, G Rahav, S Levi, A Braester, G Itchaki, O Bairey, N Dally, ...
Blood, The Journal of the American Society of Hematology 139 (5), 678-685, 2022
Merkel cell carcinoma, chronic lymphocytic leukemia and other lymphoproliferative disorders: an old bond with possible new viral ties
T Tadmor, A Aviv, A Polliack
Annals of Oncology 22 (2), 250-256, 2011
Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia
O Benjamini, L Rokach, G Itchaki, A Braester, L Shvidel, N Goldschmidt, ...
Haematologica 107 (3), 625, 2022
First-line venetoclax combinations in chronic lymphocytic leukemia
B Eichhorst, CU Niemann, AP Kater, M Fürstenau, J Von Tresckow, ...
New England Journal of Medicine 388 (19), 1739-1754, 2023
Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre-and post …
T Tadmor, A Bari, S Sacchi, L Marcheselli, EV Liardo, I Avivi, N Benyamini, ...
haematologica 99 (1), 125, 2014
Absolute monocytosis at diagnosis correlates with survival in diffuse large B‐cell lymphoma—possible link with monocytic myeloid‐derived suppressor cells
T Tadmor, R Fell, A Polliack, D Attias
Hematological oncology 31 (2), 65-71, 2013
CD30: an important new target in hematologic malignancies
YE Deutsch, T Tadmor, ER Podack, JD Rosenblatt
Leukemia & lymphoma 52 (9), 1641-1654, 2011
B lymphocyte inhibition of anti-tumor response depends on expansion of Treg but is independent of B-cell IL-10 secretion
Y Zhang, Y Eliav, S Shin, TH Schreiber, ER Podack, T Tadmor, ...
Cancer Immunology, Immunotherapy 62, 87-99, 2013
The expression of lysyl‐oxidase gene family members in myeloproliferative neoplasms
T Tadmor, J Bejar, D Attias, E Mischenko, E Sabo, G Neufeld, Z Vadasz
American journal of hematology 88 (5), 355-358, 2013
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
T Chatzikonstantinou, A Kapetanakis, L Scarfò, G Karakatsoulis, D Allsup, ...
Leukemia 35 (12), 3444-3454, 2021
Myeloid‐derived suppressor cells–their role in haemato‐oncological malignancies and other cancers and possible implications for therapy
T Tadmor, D Attias, A Polliack
British journal of haematology 153 (5), 557-567, 2011
Predicting infections in high‐risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: Aretrospective multicenter study
D Merkel, K Filanovsky, A Gafter‐Gvili, L Vidal, A Aviv, ME Gatt, ...
American journal of hematology 88 (2), 130-134, 2013
Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy
K Jamroziak, T Tadmor, T Robak, A Polliack
Leukemia & lymphoma 56 (7), 1949-1958, 2015
Ibrutinib‐associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non‐Hodgkin lymphoma: an observational study
R Ruchlemer, R Ben‐Ami, M Bar‐Meir, JR Brown, M Malphettes, R Mous, ...
Mycoses 62 (12), 1140-1147, 2019
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20